Literature DB >> 17604217

Spectrophotometric simultaneous determination of rabeprazole sodium and itopride hydrochloride in capsule dosage form.

Shweta S Sabnis1, Nilesh D Dhavale, Vijay Y Jadhav, Santosh V Gandhi.   

Abstract

A new simple, economical, rapid, precise and accurate method for simultaneous determination of rabeprazole sodium and itopride hydrochloride in capsule dosage form has been developed. The method is based on ratio spectra derivative spectrophotometry. The amplitudes in the first derivative of the corresponding ratio spectra at 231nm (minima) and 260nm were selected to determine rabeprazole sodium and itopride hydrochloride, respectively. The method was validated with respect to linearity, precision and accuracy.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17604217     DOI： 10.1016/j.saa.2007.05.048

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN： 1386-1425            Impact factor:   4.098


  6 in total

1.  Stability-indicating spectrofluorimetric method for determination of itopride hydrochloride in raw material and pharmaceutical formulations.

Authors:  Mohamed I Walash; Fawzia Ibrahim; Manal I Eid; Samah Abo El Abass
Journal:  J Fluoresc       Date:  2013-07-14       Impact factor: 2.217

2.  Liquid chromatography coupled with fluorimetric detection and third derivative synchronous fluorescence spectroscopy as two analytical methods for the simultaneous determination of rabeprazole sodium and domperidone after derivatization with 4-chloro-7-nitrobenzofurazan.

Authors:  F Ibrahim; M E K Wahba
Journal:  J Fluoresc       Date:  2014-06-03       Impact factor: 2.217

3.  Stability-indicating HPLC-DAD methods for determination of two binary mixtures: Rabeprazole sodium-mosapride citrate and rabeprazole sodium-itopride hydrochloride.

Authors:  Hamed M El-Fatatry; Mokhtar M Mabrouk; Ismail I Hewala; Ehab H Emam
Journal:  J Pharm Anal       Date:  2013-09-23

4.  Voltammetric determination of itopride using carbon paste electrode modified with Gd doped TiO2 nanotubes.

Authors:  Abdulaziz Nabil Amro; Khadijah Emran; Hessah Alanazi
Journal:  Turk J Chem       Date:  2020-08-18       Impact factor: 1.239

5.  Development and validation of dissolution testings in acidic media for rabeprazole sodium delayed-release capsules.

Authors:  Yinhe Tan; Xiaoqing Si; Lulu Zhong; Xin Feng; Xinmin Yang; Min Huang; Chuanbin Wu
Journal:  Drug Dev Ind Pharm       Date:  2016-04-11       Impact factor: 3.225

6.  Analytical method development and validation of simultaneous estimation of rabeprazole, pantoprazole, and itopride by reverse-phase high-performance liquid chromatography.

Authors:  Senthamil Selvan Perumal; Sanmuga Priya Ekambaram; Samundeswari Raja
Journal:  J Food Drug Anal       Date:  2014-10-28       Impact factor: 6.157
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.